(Q39729652)

14 September 2017

title

Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines (English)

1 reference

14 September 2017

1 reference

5

1 reference

14 September 2017

Giulia Grisendi

3

0 references

Stefano Sacchi

object named as

Stefano Sacchi

6

0 references

author name string

Monica Civallero

1

1 reference

14 September 2017

Maria Cosenza

2

1 reference

14 September 2017

Luigi Marcheselli

4

1 reference

14 September 2017

publication date

1 April 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

51

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

671-679

1 reference

Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

t(14;18), a journey to eternity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Immunodeficiency in protein kinase cbeta-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Long-term culture of human bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003637290

10.3109/10428191003637290

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference